Plasma potassium rises during muscular exercise and falls rapidly when exercise is stopped. Since the sympathoadrenal system is stimulated with exertion and both alpha- and beta-adrenergic agonists affect internal potassium homeostasis, we studied the influence of catecholamines on potassium shifts during and after exercise. Six healthy subjects were given maximal exercise stress tests under three conditions: with no medication (control), during beta-blockade with propranolol, and during alpha-blockade with phentolamine. Compared with a peak rise in plasma potassium of 1.23 +/- 0.27 mmol per liter (mean +/- S.E.M.) during the control study, propranolol caused a rise of 1.89 +/- 0.35 (P less than 0.01) and a sustained elevation during recovery. Phentolamine diminished the rise of potassium (0.70 +/- 0.21 mmol per liter; P less than 0.01) and lowered the potassium level throughout recovery. These effects of catecholamines were independent of the venous pH, the plasma bicarbonate and serum glucose levels, and urinary potassium excretion, and they did not appear to be due to insulin. High norepinephrine and epinephrine levels confirmed the release of catecholamines capable of stimulating alpha- and beta-receptors. Exercise work did not differ among the groups. beta-Adrenergic receptors appear to moderate the acute hyperkalemia of exercise, whereas alpha-adrenergic receptors act to enhance hyperkalemia and may protect against hypokalemia when exertion ceases.
This article has been cited by other articles:
Brown, R. S., Karumanchi, S. A., Sukhatme, V. P., Zeidel, M. L.
(2009). Franklin H. Epstein--Researcher, Teacher, Clinician, and Humanist. CJASN
4: 1285-1289
[Full Text]
Hawboldt, J., McGrath, D.
(2006). Possible Metoprolol-Induced Hyperkalemia. Journal of Pharmacy Practice
19: 320-325
[Abstract]
Evans, K. J., Greenberg, A.
(2005). Hyperkalemia: A Review. J Intensive Care Med
20: 272-290
[Abstract]
CLAUSEN, T.
(2003). Na+-K+ Pump Regulation and Skeletal Muscle Contractility. Physiol. Rev.
83: 1269-1324
[Abstract][Full Text]
Geleijnse, M. L., Elhendy, A., Fioretti, P. M., Roelandt, J. R. T. C.
(2000). Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol
36: 2017-2027
[Abstract][Full Text]
Doshi, S. K., Singh, B. N.
(2000). Reviews: Pure Class III Antiarrhythmic Drugs: Focus on Dofetilide. J CARDIOVASC PHARMACOL THER
5: 237-247
Botker, H. E., Sonne, H. S., Frobert, O., Andreasen, F.
(1999). Enhanced exercise-induced hyperkalemia in patients with syndrome X. J Am Coll Cardiol
33: 1056-1061
[Abstract][Full Text]
Demolis, J.-L., Funck-Brentano, C., Ropers, J., Ghadanfar, M., Nichols, D. J., Jaillon, P.
(1996). Influence of Dofetilide on QT-Interval Duration and Dispersion at Various Heart Rates During Exercise in Humans. Circulation
94: 1592-1599
[Abstract][Full Text]
Skorodin, M. S.
(1993). Pharmacotherapy for Asthma and Chronic Obstructive Pulmonary Disease: Current Thinking, Practices, and Controversies. Arch Intern Med
153: 814-828
[Abstract]
Lang, D. M., Alpern, M. B., Visintainer, P. F., Smith, S. T.
(1991). Increased Risk for Anaphylactoid Reaction from Contrast Media in Patients on {beta}-Adrenergic Blockers or with Asthma. ANN INTERN MED
115: 270-276
[Abstract]
Kelley, D. E., Gharib, H., Kennedy, F. P., Duda, R. J. Jr, McManis, P. G.
(1989). Thyrotoxic Periodic Paralysis: Report of 10 Cases and Review of Electromyographic Findings. Arch Intern Med
149: 2597-2600
[Abstract]
Ades, P. A., Gunther, P. G.S., Meacham, C. P., Handy, M. A., LeWinter, M. M.
(1988). Hypertension, Exercise, and Beta-Adrenergic Blockade. ANN INTERN MED
109: 629-634
[Abstract]
Williams, M. E., Rosa, R. M.
(1988). Hyperkalemia: Disorders of Internal and External Potassium Balance. J Intensive Care Med
3: 52-64
[Abstract]
Previous
